| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.45B | 34.64B | 25.79B | 22.68B | 23.60B | 16.43B |
| Gross Profit | 18.83B | 17.15B | 12.72B | 10.46B | 10.60B | 7.93B |
| EBITDA | 7.17B | 7.28B | 5.26B | 4.15B | 5.53B | 4.17B |
| Net Income | 4.99B | 4.33B | 1.64B | 854.00M | 1.32B | 3.16B |
Balance Sheet | ||||||
| Total Assets | 79.64B | 76.93B | 69.23B | 67.89B | 67.58B | 12.42B |
| Cash, Cash Equivalents and Short-Term Investments | 12.35B | 10.55B | 5.13B | 5.77B | 5.86B | 3.61B |
| Total Debt | 3.87B | 4.47B | 2.21B | 3.00B | 2.86B | 661.00M |
| Total Liabilities | 15.18B | 13.93B | 11.66B | 11.99B | 12.83B | 4.92B |
| Stockholders Equity | 64.46B | 63.00B | 57.57B | 55.89B | 54.75B | 7.50B |
Cash Flow | ||||||
| Free Cash Flow | 8.57B | 6.74B | 2.40B | 1.12B | 3.12B | 3.22B |
| Operating Cash Flow | 9.72B | 7.71B | 3.04B | 1.67B | 3.56B | 3.52B |
| Investing Cash Flow | -7.74B | -5.53B | -1.10B | -1.42B | 2.00B | -686.00M |
| Financing Cash Flow | -2.45B | -431.00M | -2.06B | -1.15B | -3.26B | -1.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
87 Outperform | $5.23T | 26.37 | 104.37% | 0.02% | 65.47% | 66.12% | |
84 Outperform | $842.20B | 8.48 | 40.84% | 0.20% | 85.55% | 410.18% | |
79 Outperform | $742.23B | 60.29 | 8.05% | ― | 34.97% | 123.87% | |
79 Outperform | $2.04T | 53.40 | 32.85% | 0.69% | 25.22% | 145.70% | |
76 Outperform | $230.92B | 4.59 | 40.19% | 2.01% | 5.21% | -6.72% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | $627.85B | -14.70 | -2.95% | ― | 1.36% | 86.07% |